{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:01:30Z","timestamp":1789790490813,"version":"4.0.1"},"reference-count":54,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Early detection and diagnosis of cancer is associated with greater treatment success and improved survival. Community pharmacies are often the first point of contact for patients with symptoms that could be due to cancer (e.g. persistent cough, rectal bleeding, dysphagia), and could contribute to earlier cancer detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review assessed the evidence for community pharmacy-based interventions to support the early detection of cancer. Five databases (Medline, EMBASE, HMIC, CINAHL, and PSYCINFO) and other supplementary sources were searched for the time period January 2000\u2013February 2025. Standard systematic review methodology following PRISMA guidelines was used. Independent duplicate screening, study selection, data extraction, and quality assessment were undertaken.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>In total, 27 studies from 10 countries were included. Several cancer types were represented including colorectal (n\u2009=\u200913), lung (n\u2009=\u20094), skin (n\u2009=\u20094), breast (n\u2009=\u20091), prostate (n\u2009=\u20091), breast and cervical (n\u2009=\u20091), gastric (n\u2009=\u20091), colorectal and prostate (n\u2009=\u20091) and one study included multiple cancer types. The interventions included targeted screening (n\u2009=\u20092), population screening (n\u2009=\u200915), triage (n\u2009=\u20098) and health promotion (n\u2009=\u20092). From the 10 studies that reported cancer diagnosis rates, 3274 individuals had cancerous or precancerous lesions detected: colorectal (n\u2009=\u20092816); prostate (n\u2009=\u200914); and skin (n\u2009=\u2009453), with a referral conversion rate ranging between 3.4% and 8.5%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Harnessing the expertise of community pharmacy personnel is likely to support patients in an earlier and faster diagnosis of cancer. The integration of community pharmacy into early detection pathways is key to maximizing their potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijpp\/riag126","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:46:19Z","timestamp":1787312779000},"source":"Crossref","is-referenced-by-count":0,"title":["Interventions to promote the early detection of cancer in community pharmacies: a systematic review"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5784-4779","authenticated-orcid":false,"given":"Shereen","family":"Nabhani Gebara","sequence":"first","affiliation":[{"name":"Professor of Oncology at Kingston University London, Department of Pharmacy, Kingston Upon Thames, KT12EE and Chair of British Oncology Pharmacy Association (BOPA) ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie McFadyen","family":"Weir","sequence":"additional","affiliation":[{"name":"Lecturer\/Community Pharmacist Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde , Glasgow G1 1XQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2049-5691","authenticated-orcid":false,"given":"Lisa","family":"Macleod","sequence":"additional","affiliation":[{"name":"Research Pharmacist, University of Stirling , Stirling FK9 4NH,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Winter","sequence":"additional","affiliation":[{"name":"Consultant Medical Consultant, University Hospitals Bristol and Weston NHS Foundation Trust , Bristol BS1 3NU,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ade","family":"Williams","sequence":"additional","affiliation":[{"name":"Superintendent Pharmacist, Bedminster Pharmacy , Bristol BS3 4EJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-9273","authenticated-orcid":false,"given":"Margaret","family":"Watson","sequence":"additional","affiliation":[{"name":"Professor of Health Service Research and Pharmacy Practice, University of Strathclyde, Glasgow G1 1XQ and Director, Watson and Training Limited , Aberdeen ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2026091823020036900_ref1","volume-title":"Cancer [Internet]","author":"World Health Organisation","year":"2022"},{"key":"2026091823020036900_ref2","first-page":"48","volume-title":"Guide to Cancer Early Diagnosis [Internet]","author":"World Health Organisation","year":"2017"},{"key":"2026091823020036900_ref3","author":"Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey [Internet]"},{"key":"2026091823020036900_ref4","author":"Cancer [Internet]"},{"key":"2026091823020036900_ref5","doi-asserted-by":"publisher","first-page":"e21697","DOI":"10.2196\/21697","article-title":"The impact of COVID-19 on cancer screening: challenges and opportunities","volume":"6","author":"Cancino","year":"2020","journal-title":"JMIR Cancer"},{"key":"2026091823020036900_ref6","volume-title":"Cancer in the UK 2025 - Socio Economic Deprivation"},{"key":"2026091823020036900_ref7","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1002\/cncr.34327","article-title":"Association of area-level socioeconomic status and non\u2013small cell lung cancer stage by race\/ethnicity and health care\u2013level factors: analysis of the National Cancer Database","volume":"128","author":"Gupta","year":"2022","journal-title":"Cancer"},{"key":"2026091823020036900_ref8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3399\/bjgp22X718865","article-title":"Can early cancer detection be improved in deprived areas by involving community pharmacists?","volume":"72","author":"Konya","year":"2022","journal-title":"Br J Gen Pract"},{"key":"2026091823020036900_ref9","volume-title":"The Legal and Regulatory Framework for Community Pharmacies in the WHO European Region"},{"key":"2026091823020036900_ref10","volume-title":"Beating Non-communicable Diseases in the Community the Contribution of Pharmacists","author":"International Pharmaceutical Federation (FIP)","year":"2019"},{"key":"2026091823020036900_ref11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/pubmed\/fdi032","article-title":"Use of community pharmacies: a population-based survey","volume":"27","author":"Boardman","year":"2005","journal-title":"J Public Health Oxf"},{"key":"2026091823020036900_ref12","article-title":"Third of patients visited community pharmacies in place of their GP during the COVID-19 pandemic, NPA survey finds","author":"Burns","year":"2020","journal-title":"Pharm J"},{"key":"2026091823020036900_ref13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.canep.2015.07.011","article-title":"Promoting the early detection of cancer: a systematic review of community pharmacy-based education and screening interventions","volume":"39","author":"Lindsay","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"2026091823020036900_ref14","author":"Slow progress with cancer pilots [Internet]"},{"key":"2026091823020036900_ref15","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"2026091823020036900_ref16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/her\/cyh022","article-title":"A causal modeling approach to the development of theory-based behaviour change programmes for trial evaluation","volume":"20","author":"Hardeman","year":"2006","journal-title":"Health Educ Res"},{"key":"2026091823020036900_ref17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3233\/EFI-180221","article-title":"The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"Hong","year":"2018","journal-title":"Educ Inf"},{"key":"2026091823020036900_ref18","doi-asserted-by":"publisher","first-page":"e000772","DOI":"10.1136\/bmjresp-2020-000772","article-title":"Feasibility and acceptability of a community pharmacy referral service for suspected lung cancer symptoms","volume":"8","author":"Holland-Hart","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"2026091823020036900_ref19","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.japh.2020.02.014","article-title":"Pharmacist intervention in colorectal cancer screening initiative","volume":"60","author":"Holle","year":"2020","journal-title":"J Am Pharm Assoc"},{"key":"2026091823020036900_ref20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1365-2753.2007.00677.x","article-title":"Accessing rural populations: role of the community pharmacist in a breast and cervical cancer screening programme","volume":"13","author":"McGuire","year":"2007","journal-title":"J Eval Clin Pract"},{"key":"2026091823020036900_ref21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11096-015-0078-3","article-title":"Widening the scope for early cancer detection: identification of alarm symptoms by community pharmacies","volume":"37","author":"Badenhorst","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"2026091823020036900_ref22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ijnurstu.2003.05.002","article-title":"Achieving change in the NHS: a study to explore the feasibility of a home-based cancer chemotherapy service","volume":"41","author":"Kelly","year":"2004","journal-title":"Int J Nurs Stud"},{"key":"2026091823020036900_ref23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/pharmacy8040231","article-title":"Accessing mole-scanning through community pharmacy: a pilot Service in Collaboration with dermatology specialists","volume":"8","author":"Kirkdale","year":"2020","journal-title":"Pharm J Pharm Educ Pract"},{"key":"2026091823020036900_ref24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1185\/03007995.2015.1135113","article-title":"A model for assessment and referral of clients with bowel symptoms in community pharmacies","volume":"32","author":"Sriram","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"2026091823020036900_ref25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1331\/JAPhA.2010.09199","article-title":"Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign","volume":"50","author":"Potter","year":"2010","journal-title":"J Am Pharm Assoc"},{"key":"2026091823020036900_ref26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1592\/phco.21.2.243.34100","article-title":"Results of a community pharmacy-based breast cancer risk-assessment and education program","volume":"21","author":"Giles","year":"2001","journal-title":"Pharmacotherapy"},{"key":"2026091823020036900_ref27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1023\/a:1017569621165","article-title":"Pilot study of the practical relevance of a one-step test for prostate-specific antigen in capillary blood to improve the acceptance rate in the early detection program of prostate carcinoma","volume":"32","author":"Berg","year":"2001","journal-title":"Int Urol Nephrol"},{"key":"2026091823020036900_ref28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1331\/1544-3191.44.5.569.boyle","article-title":"Men\u2019s health initiative risk assessment study: effect of community pharmacy-based screening","volume":"44","author":"Boyle","year":"2004","journal-title":"J Am Pharm Assoc JAPhA"},{"key":"2026091823020036900_ref29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1078155215616278","article-title":"Evaluating the appropriateness of a community pharmacy model for a colorectal cancer screening program in Catalonia (Spain)","volume":"23","author":"Santolaya","year":"2017","journal-title":"J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract"},{"key":"2026091823020036900_ref30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.medcle.2016.01.019","article-title":"Colorectal cancer early screening program of Barcelona, Spain: indicators of the first round of a program with participation of community pharmacies","volume":"145","author":"Bur\u00f3n","year":"2015","journal-title":"Med Cl\u00ednica Engl Ed"},{"key":"2026091823020036900_ref31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.gastrohep.2016.04.015","article-title":"Analysis of participant satisfaction in the Barcelona colorectal cancer screening programme: positive evaluation of the community pharmacy","volume":"40","author":"Bur\u00f3n","year":"2017","journal-title":"Gastroenterol Hepatol"},{"key":"2026091823020036900_ref32","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.sapharm.2016.12.001","article-title":"Dermatological cancer screening: evaluation of a new community pharmacy service","volume":"13","author":"Kjome","year":"2017","journal-title":"Res Soc Adm Pharm RSAP"},{"key":"2026091823020036900_ref33","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.18549\/PharmPract.2019.3.1455","article-title":"Role of community pharmacists in skin cancer screening: a descriptive study of skin cancer risk factors prevalence and photoprotection habits in Barcelona, Catalonia, Spain","volume":"17","author":"Mir","year":"2019","journal-title":"Pharm Pract"},{"key":"2026091823020036900_ref34","first-page":"348","article-title":"Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies","volume":"100","author":"Pippa","year":"2009","journal-title":"Recenti Prog Med"},{"key":"2026091823020036900_ref35","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s11096-019-00899-z","article-title":"Experience with a colorectal cancer campaign in Swiss pharmacies","volume":"41","author":"Ruggli","year":"2019","journal-title":"Int J Clin Pharm"},{"key":"2026091823020036900_ref36","doi-asserted-by":"publisher","first-page":"106420","DOI":"10.1016\/j.ypmed.2021.106420","article-title":"Role of community pharmacies in a population-based colorectal cancer screening program","volume":"145","author":"Vives","year":"2021","journal-title":"Prev Med"},{"key":"2026091823020036900_ref37","first-page":"83","article-title":"Piloting and validating an innovation to triage patients presenting with cough to community pharmacies in Western Australia","volume":"20","author":"Jiwa","year":"2012","journal-title":"Qual Prim Care"},{"key":"2026091823020036900_ref38","first-page":"28","article-title":"Triaging consumers who present bowel symptoms to community pharmacies: a pilot study of two interventions","author":"Jiwa","year":"2009","journal-title":"Aust Pharm"},{"key":"2026091823020036900_ref39","first-page":"105","article-title":"Could community pharmacies offer an opportunity to improve outcomes for patients with bowel cancer?","volume":"19","author":"Jiwa","year":"2011","journal-title":"Qual Prim Care"},{"key":"2026091823020036900_ref40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/1715163520903065","article-title":"Community pharmacy-based H. pylori screening for patients with uninvestigated dyspepsia","volume":"153","author":"Papastergiou","year":"2020","journal-title":"Can Pharm J CPJ Rev Pharm Can RPC"},{"key":"2026091823020036900_ref41","author":"A Lung Health Service: Doncaster Pharmacy Direct Referral For Chest X-Ray: A project summary [Internet]"},{"key":"2026091823020036900_ref42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5688\/aj7308154","article-title":"Roles of innovation in education delivery","volume":"73","author":"Blouin","year":"2009","journal-title":"Am J Pharm Educ"},{"key":"2026091823020036900_ref43","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.japh.2020.10.004","article-title":"SCAN! A pharmacy-based, sun safety feasibility study","volume":"61","author":"Kelly","year":"2021","journal-title":"J Am Pharm Assoc JAPhA"},{"key":"2026091823020036900_ref44","article-title":"How a pharmacy-led lung cancer awareness campaign met NHS aims","author":"Phillips","journal-title":"The Pharmaceutical Journal [Internet]"},{"key":"2026091823020036900_ref45","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.japh.2022.11.012","article-title":"Assessing the effects of pharmacist education on colorectal cancer screening and access to a stool-based DNA test","volume":"63","author":"Moore","year":"2023","journal-title":"J Am Pharm Assoc"},{"key":"2026091823020036900_ref46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.sapharm.2024.12.006","article-title":"Community pharmacist-led point-of-care colorectal cancer screening program: early detection of colorectal cancer in high-risk patients","volume":"21","author":"Jairoun","year":"2025","journal-title":"Res Soc Adm Pharm"},{"key":"2026091823020036900_ref47","author":"Cancer Research UK [Internet]","year":"2017"},{"key":"2026091823020036900_ref48","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1136\/gutjnl-2011-300843","article-title":"Outcomes of the bowel cancer screening programme (BCSP) in England after the first 1 million tests","volume":"61","author":"Logan","year":"2012","journal-title":"Gut"},{"key":"2026091823020036900_ref49","doi-asserted-by":"publisher","first-page":"S959","DOI":"10.1016\/j.annonc.2025.08.2377","article-title":"1748P evaluating the impact of C the signs: AI-driven early cancer detection in primary care across Somerset ICB","volume":"36","author":"Dadhania","year":"2025","journal-title":"Ann Oncol"},{"key":"2026091823020036900_ref50","author":"Tackling the inverse care law - The Health Foundation [Internet]"},{"key":"2026091823020036900_ref51","volume-title":"NHS Long Term Plan","author":"NHS Long Term Plan [Internet]"},{"key":"2026091823020036900_ref52","volume-title":"The National Cancer Plan for England: Delivering World Class Cancer Care"},{"key":"2026091823020036900_ref53","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3399\/BJGP.2025.0204","article-title":"Early cancer diagnosis and community pharmacies \u2013 a systematic review","author":"Konya","year":"2025","journal-title":"Br J Gen Pract"},{"key":"2026091823020036900_ref54","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.3399\/bjgp17X690869","article-title":"Emergency diagnosis of cancer and previous general practice consultations: insights from linked patient survey data","volume":"67","author":"Abel","year":"2017","journal-title":"Br J Gen Pract"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article-pdf\/doi\/10.1093\/ijpp\/riag126\/71228058\/riag126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article-pdf\/doi\/10.1093\/ijpp\/riag126\/71228058\/riag126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:02:16Z","timestamp":1789786936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article\/doi\/10.1093\/ijpp\/riag126\/8817557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":54,"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riag126","relation":{},"ISSN":["2042-7174"],"issn-type":[{"value":"2042-7174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"riag126"}}